What Counts as "Medical Necessity" for GLP-1s: The Documentation Standard

Medical Necessity: The Standard Every Insurer Uses

"Medical necessity" is the threshold your prescription must clear for insurance coverage. It's not enough to want a GLP-1 medication or even to qualify clinically — your insurer needs documentation that treatment is necessary for your health, not elective or cosmetic.

The medical necessity standard for GLP-1 prescribing generally requires three things: (1) a qualifying diagnosis (obesity or overweight with comorbidities), (2) evidence that the condition has been or is being managed through behavioral interventions, and (3) a clinician's judgment that pharmacotherapy is the appropriate next step.

What separates successful prior authorizations from denials is almost always documentation quality, not clinical qualification. Many patients who are clearly appropriate for GLP-1 treatment get denied because the paperwork doesn't tell the full story.

The Documentation Checklist That Gets Approvals

• BMI measurements: At least two documented BMI measurements from clinical visits, ideally showing a sustained elevated BMI over 6+ months
• Comorbidity documentation: Diagnosis codes (ICD-10) for each weight-related condition, with supporting lab work or clinical findings
• Lab results: A1C, fasting glucose, lipid panel, and any other relevant metabolic markers — ideally from within the past 6 months
• Prior treatment history: Records of previous weight management attempts — nutritionist visits, exercise programs, prior medications, behavioral counseling
• Treatment failure evidence: Documentation showing that prior interventions didn't achieve or maintain a clinically significant weight reduction (usually defined as ≥5%)
• Letter of medical necessity: A detailed letter from your prescriber explaining the clinical rationale for GLP-1 therapy, referencing current guidelines and your individual health profile
• Medication reconciliation: A current medication list showing that GLP-1 therapy doesn't duplicate an existing treatment

How to Build a Medical Record That Supports GLP-1 Prescribing

If you're planning to pursue insurance-covered GLP-1 treatment, start building your medical record proactively. Here's a timeline:

Months 1-3: Establish the baseline. Schedule a visit with your PCP. Get your BMI documented, run a comprehensive metabolic panel and lipid panel, and discuss your weight management goals. Ask for a referral to a nutritionist or registered dietitian. This visit creates the "starting documentation" that insurers want to see.

Months 2-4: Document the intervention. Attend the nutritionist/dietitian appointments. Follow the recommended dietary and exercise plan. Keep a food and exercise log. Weigh in at clinical visits (not just at home). This creates the "prior treatment attempt" documentation.

Month 4-6: Document the outcome. Return to your PCP for a follow-up. Get your weight and BMI re-documented. Run labs again. If you haven't achieved a ≥5% weight reduction through behavioral intervention alone, your prescriber now has documented evidence of treatment failure — the key criterion for step therapy completion.

This timeline moves you from zero documentation to a strong prior authorization package in about six months. If you already have existing documentation from prior visits, you may be able to shortcut this process significantly.

The Clinical Guidelines Your Insurer Is Using

Most insurers base their medical necessity criteria on some combination of the following clinical guidelines:

FDA-approved indications: BMI ≥ 30, or BMI ≥ 27 with at least one weight-related comorbidity. This is the baseline.

Endocrine Society guidelines: Recommend pharmacotherapy for patients with BMI ≥ 27 who haven't achieved target weight loss through lifestyle intervention alone.

AMA/Obesity Medicine Association: Recognize obesity as a chronic disease requiring ongoing treatment, including pharmacotherapy when clinically appropriate.

AACE/ACE guidelines: Recommend anti-obesity medications as part of a comprehensive treatment plan for patients with obesity-related complications.

When your prescriber writes the letter of medical necessity, referencing the specific guideline that supports your case strengthens the argument considerably. Insurers' medical directors are physicians — they respond to clinical evidence and guideline citations.